Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
Annals of Nuclear Medicine|April 24, 2024
Safety and efficacy of multiple-dose versus single-dose MIBG therapy in patients with refractory pheochromocytoma and paraganglioma: a single-center retrospective analysisNaoto Wakabayashi, Shiro Watanabe, Takashige Abe, et al.
Annals of Nuclear Medicine|April 5, 2025
Factors and predictors affecting late external dose rates and isolation period in patients after lutetium-177-labeled DOTA-Tyr3-octreotate treatment for neuroendocrine tumorsNaoto Wakabayashi, Shiro Watanabe, Satoshi Takeuchi, et al.
Diagnostics (Basel, Switzerland)|June 13, 2025
The Biochemical-Imaging Connection: Urinary Noradrenaline and Fluorodeoxyglucose-Positron Emission Tomography in Unresectable or Metastatic Pheochromocytomas and ParagangliomasJunki Takenaka, Shiro Watanabe, Takashige Abe, et al.
Pharmaceuticals (Basel, Switzerland)|February 26, 2025
Urinary Dopamine Levels Can Predict the Avidity of Post-Therapy [<sup>131</sup>I]MIBG Scintigraphy in Unresectable or Metastatic Pheochromocytomas and Paragangliomas: A Preliminary Clinical StudyJunki Takenaka, Shiro Watanabe, Takashige Abe, et al.
Neuroendocrinology|September 19, 2023
Predictive Factors of Early 18F-Fluorodeoxyglucose-Positron Emission Tomography Response to [131I] Metaiodobenzylguanidine Treatment for Unresectable or Metastatic Pheochromocytomas and ParagangliomasJunki Takenaka, Shiro Watanabe, Takashige Abe, et al.
Annals of Nuclear Medicine|August 16, 2022
Identification of patients with Graves' disease who benefit from high-dose radioactive iodine therapyShiro Watanabe, Shozo Okamoto, Kazumasa Akikawa, et al.
Frontiers in Oncology|February 20, 2026
Spinal decompression and radionuclide therapy for an unresectable FGF23 transmitted tumor causing cervical myelopathy: a case report and literature reviewShin Yokoyama, Hirokazu Shimizu, Akiko Yuno, et al.
Pageof 2